← Sticker Wall MODEL · DETAIL

Traditional Chinese Medicine Full-Link Digital-Intelligence Traceability Platform

1) Annual traceability SaaS service fees charged based on connected nodes and code issuance volume; 2) Undertaking gover

MODEL

Key Fields

FIELD STAMPS

IndustryHealthcare / Elderly Care

RegionChina

ScaleMid-size

ChannelHybrid

📌 Background

In 2026, the capitalization of Traditional Chinese Medicine (TCM) data enters the implementation phase, yet data across planting, processing, circulation, and diagnosis remains isolated. Full-link traceability has become a shared bet for both regulatory policies and leading pharmaceutical enterprises. The Yuantang system debuted in Chongqing as digital-intelligence TCM infrastructure, while Kangmei Pharmaceutical empowers the entire TCM chain with AI. Darentang is the fastest-running time-honored brand, with its digital transformation index surging by 31.43% from late 2023 to late 2025 (according to public disclosures, independent verification pending).

👤 Target Customers

TCM decoction piece factories, proprietary Chinese medicine enterprises, chain TCM clinics, and government medical products regulatory departments, with pharmaceutical enterprises and government-funded projects serving as the primary payers.

💰 Revenue Streams

1) Annual traceability SaaS service fees charged based on connected nodes and code issuance volume; 2) Undertaking government TCM quality digitization projects; 3) Providing assetization consulting and transaction matchmaking services based on accumulated data.

🧮 Cost Structure

Investment in IoT collection equipment and planting base upgrades, platform R&D and O&M, cross-enterprise data governance labor, and market channel costs.

🛡️ Moat

Full-link data foundation and industry standard-setting power, network effects formed by early-mover connected nodes, and switching costs driven by co-building with leading pharmaceutical enterprises.

🔑 Keys to Success

Securing benchmark production area government projects and top-tier chain clients
Establishing a sustainable cross-enterprise data sharing and profit-sharing mechanism
Bundling traceability data with value-added services such as insurance and supply chain finance

⚠️ Risks

Risks related to data compliance and trade secret leaks
Extended implementation cycles caused by weak information infrastructure in agriculture-related segments
Asset-heavy model dragging down the speed of large-scale replication

🏢 Cases

Yuantang Digital-Intelligence TCM Infrastructure System
Kangmei Pharmaceutical AI Full-Link TCM Intelligent Platform
Darentang Digital-Intelligence Transformation

📊 SWOT Analysis

Strengths

Covers the full link from planting to diagnosis with comprehensive data dimensions
Policy support for data assetization, where compliance barriers create natural moats
Co-creation of benchmarks with leading pharmaceutical enterprises, providing strong industry endorsement

Weaknesses

Heavy deployment of IoT hardware with large upfront capital investment
Trust and profit-distribution challenges in interconnecting cross-enterprise data

Opportunities

Accelerating integration of TCM data assets into financial statements, increasing corporate willingness to pay
TCM going global driving demand for internationalized traceability standards

Threats

Inconsistent regional data standards, making cross-province interoperability highly difficult
Self-built platforms by large pharmaceutical enterprises potentially squeezing the space for third-party service providers

Sources